http://www.healthbusinessblog.com/?p=1072 Focusing on business issues in health care. Written by David E. Williams of MedPharma Partners Tue, 07 Sep 2010 20:12:43 +0000 hourly 1 http://wordpress.org/?v=3.0 http://www.healthbusinessblog.com/?p=1072&cpage=1#comment-12153 Health Business Blog » Blog Archive » Is a big pharma LBO on the horizon? Thu, 14 Jun 2007 03:00:29 +0000 http://www.healthbusinessblog.com/?p=1072#comment-12153 [...] With AstraZeneca’s CFO Jon Symonds leaving for Goldman Sachs, I wonder if it’s a sign we’ll see someone have a go at taking a big pharma company private. I wrote about the concept here. +del.icio.us +Digg it [...] [...] With AstraZeneca’s CFO Jon Symonds leaving for Goldman Sachs, I wonder if it’s a sign we’ll see someone have a go at taking a big pharma company private. I wrote about the concept here. +del.icio.us +Digg it [...]

]]> http://www.healthbusinessblog.com/?p=1072&cpage=1#comment-892 streeter Thu, 25 Jan 2007 12:31:20 +0000 http://www.healthbusinessblog.com/?p=1072#comment-892 This is what Millennium Pharmaceuticals is attempting to accomplish. No breakup required. Key is that they do not expect a Billion $ molecule. Instead they are structured to be profitable with $300 - $600 Million products. This is what Millennium Pharmaceuticals is attempting to accomplish. No breakup required. Key is that they do not expect a Billion $ molecule. Instead they are structured to be profitable with $300 – $600 Million products.

]]>